Abstract

<p>As every year, the 68<sup>th</sup> American College of Cardiology (ACC) conference was held in New Orleans, Louisiana, from March 16 to 18. With carnival and jazzas the background, he convened the world cardiology again to promote knowledge by displaying a variety of scientific activities. More than 16000 participants attended and 2300 articles were received, many of which will undoubtedly change current clinical practice. It is also worth noting that the introduction of the guidelines for primary pretreatment of cardiovascular diseases emphasizes that acetylsalicylic acid is almost completely abandoned in primary pretreatment due to the lack of net profit.</p><p>We will briefly summarize some of the major scientific papers submitted:</p><p>1. Antithrombotic therapy after PCI for acute coronary syndrome or atrial fibrillation—Augustus test</p><p>2. Transcatheter aortic valve replacement and balloon dilatation in low-risk patients-partner 3 trial</p><p>3. Safety and effectiveness of STEMI femoral artery access: Safari STEMI trial</p><p>4. One month after drug-eluting stent implantation, clopidogrel monotherapy was compared with clopidogrel standard 12-month dual antiplatelet therapy. Stop dapt 2 test</p><p>5. Results of a large-scale application based study using Smartwatch to identify atrial fibrillation: Apple heart research</p>

Full Text
Paper version not known

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call

Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.